Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

409 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A comparison of two invasive strategies in patients with non-ST elevation acute coronary syndromes: results of the Early or Late Intervention in unStable Angina (ELISA) pilot study. 2b/3a upstream therapy and acute coronary syndromes.
van 't Hof AW, de Vries ST, Dambrink JH, Miedema K, Suryapranata H, Hoorntje JC, Gosselink AT, Zijlstra F, de Boer MJ. van 't Hof AW, et al. Eur Heart J. 2003 Aug;24(15):1401-5. doi: 10.1016/s0195-668x(03)00259-8. Eur Heart J. 2003. PMID: 12909068 Clinical Trial.
Facilitation of primary coronary angioplasty by early start of a glycoprotein 2b/3a inhibitor: results of the ongoing tirofiban in myocardial infarction evaluation (On-TIME) trial.
van 't Hof AW, Ernst N, de Boer MJ, de Winter R, Boersma E, Bunt T, Petronio S, Marcel Gosselink AT, Jap W, Hollak F, Hoorntje JC, Suryapranata H, Dambrink JH, Zijlstra F; On-TIME study group. van 't Hof AW, et al. Eur Heart J. 2004 May;25(10):837-46. doi: 10.1016/j.ehj.2004.04.003. Eur Heart J. 2004. PMID: 15140531 Clinical Trial.
Platelet microaggregation inhibition in patients with acute myocardial infarction pretreated with tirofiban and relationship with angiographic and clinical outcome.
Smit JJ, Ernst NM, Slingerland RJ, Kolkman JJ, Suryapranata H, Hoorntje JC, Dambrink JH, Ottervanger JP, Gosselink AT, de Boer MJ, van 't Hof AW; On-TIME Study Group. Smit JJ, et al. Am Heart J. 2006 May;151(5):1102-7. doi: 10.1016/j.ahj.2005.05.025. Am Heart J. 2006. PMID: 16644344 Clinical Trial.
Reperfusion after primary angioplasty for ST-elevation myocardial infarction: predictors of success and relationship to clinical outcomes in the APEX-AMI angiographic study.
Brener SJ, Moliterno DJ, Aylward PE, van't Hof AW, Ruźyllo W, O'Neill WW, Hamm CW, Westerhout CM, Granger CB, Armstrong PW; APEX-AMI Investigators. Brener SJ, et al. Eur Heart J. 2008 May;29(9):1127-35. doi: 10.1093/eurheartj/ehn125. Epub 2008 Mar 27. Eur Heart J. 2008. PMID: 18375399
Prehospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergoing primary angioplasty (On-TIME 2): a multicentre, double-blind, randomised controlled trial.
Van't Hof AW, Ten Berg J, Heestermans T, Dill T, Funck RC, van Werkum W, Dambrink JH, Suryapranata H, van Houwelingen G, Ottervanger JP, Stella P, Giannitsis E, Hamm C; Ongoing Tirofiban In Myocardial infarction Evaluation (On-TIME) 2 study group. Van't Hof AW, et al. Lancet. 2008 Aug 16;372(9638):537-46. doi: 10.1016/S0140-6736(08)61235-0. Lancet. 2008. PMID: 18707985 Clinical Trial.
Tirofiban for myocardial infarction.
Juwana YB, Suryapranata H, Ottervanger JP, van 't Hof AW. Juwana YB, et al. Expert Opin Pharmacother. 2010 Apr;11(5):861-6. doi: 10.1517/14656561003690005. Expert Opin Pharmacother. 2010. PMID: 20210689 Review.
409 results